A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
Clinical trial NCT02632305 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02632305
- Sponsor
- AHS Cancer Control Alberta
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-13
- Primary completion
- 2026-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.